Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy

Structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene

E. Viggiano, A. Marabotti, A. P. Burlina, C. Cazzorla, M. R. D'Apice, L. Giordano, I. Fasan, G. Novelli, A. Facchiano, A. B. Burlina

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Classical galactosemia is an autosomal recessive inborn error of metabolism due to mutations of the GALT gene leading to toxic accumulation of galactose and derived metabolites. With the benefit of early diagnosis by neonatal screening and early therapy, the acute presentation of classical galactosemia can be prevented. However, despite early diagnosis and treatment, the long term outcome for these patients is still unpredictable because they may go on to develop cognitive disability, speech problems, neurological and/or movement disorders and, in females, ovarian dysfunction. The objectives of the current study were to report our experience with a group of galactosemic patients identified through the neonatal screening programs in northeastern Italy during the last 30. years.No neonatal deaths due to galactosemia complications occurred after the introduction of the neonatal screening program. However, despite the early diagnosis and dietary treatment, the patients with classical galactosemia showed one or more long-term complications.A total of 18 different variations in the GALT gene were found in the patient cohort: 12 missense, 2 frameshift, 1 nonsense, 1 deletion, 1 silent variation, and 1 intronic. Six (p.R33P, p.G83V, p.P244S, p.L267R, p.L267V, p.E271D) were new variations. The most common variation was p.Q188R (12 alleles, 31.5%), followed by p.K285N (6 alleles, 15.7%) and p.N314D (6 alleles, 15.7%). The other variations comprised 1 or 2 alleles. In the patients carrying a new mutation, the biochemical analysis of GALT activity in erythrocytes showed an activity of

Original languageEnglish
Pages (from-to)112-118
Number of pages7
JournalGene
Volume559
Issue number2
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

UTP-Hexose-1-Phosphate Uridylyltransferase
Neonatal Screening
Galactosemias
Italy
Alleles
Early Diagnosis
Genes
Inborn Errors Metabolism
Mutation
Poisons
Movement Disorders
Secondary Prevention
Nervous System Diseases
Galactose
Erythrocytes
Therapeutics

Keywords

  • Classic galactosemia
  • GALT variations
  • In silico analysis
  • Long-term outcome

ASJC Scopus subject areas

  • Genetics
  • Medicine(all)

Cite this

Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy : Structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene. / Viggiano, E.; Marabotti, A.; Burlina, A. P.; Cazzorla, C.; D'Apice, M. R.; Giordano, L.; Fasan, I.; Novelli, G.; Facchiano, A.; Burlina, A. B.

In: Gene, Vol. 559, No. 2, 01.04.2015, p. 112-118.

Research output: Contribution to journalArticle

Viggiano, E. ; Marabotti, A. ; Burlina, A. P. ; Cazzorla, C. ; D'Apice, M. R. ; Giordano, L. ; Fasan, I. ; Novelli, G. ; Facchiano, A. ; Burlina, A. B. / Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy : Structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene. In: Gene. 2015 ; Vol. 559, No. 2. pp. 112-118.
@article{2b1a81f56dd14e6eb1515b54f2a41581,
title = "Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy: Structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene",
abstract = "Classical galactosemia is an autosomal recessive inborn error of metabolism due to mutations of the GALT gene leading to toxic accumulation of galactose and derived metabolites. With the benefit of early diagnosis by neonatal screening and early therapy, the acute presentation of classical galactosemia can be prevented. However, despite early diagnosis and treatment, the long term outcome for these patients is still unpredictable because they may go on to develop cognitive disability, speech problems, neurological and/or movement disorders and, in females, ovarian dysfunction. The objectives of the current study were to report our experience with a group of galactosemic patients identified through the neonatal screening programs in northeastern Italy during the last 30. years.No neonatal deaths due to galactosemia complications occurred after the introduction of the neonatal screening program. However, despite the early diagnosis and dietary treatment, the patients with classical galactosemia showed one or more long-term complications.A total of 18 different variations in the GALT gene were found in the patient cohort: 12 missense, 2 frameshift, 1 nonsense, 1 deletion, 1 silent variation, and 1 intronic. Six (p.R33P, p.G83V, p.P244S, p.L267R, p.L267V, p.E271D) were new variations. The most common variation was p.Q188R (12 alleles, 31.5{\%}), followed by p.K285N (6 alleles, 15.7{\%}) and p.N314D (6 alleles, 15.7{\%}). The other variations comprised 1 or 2 alleles. In the patients carrying a new mutation, the biochemical analysis of GALT activity in erythrocytes showed an activity of",
keywords = "Classic galactosemia, GALT variations, In silico analysis, Long-term outcome",
author = "E. Viggiano and A. Marabotti and Burlina, {A. P.} and C. Cazzorla and D'Apice, {M. R.} and L. Giordano and I. Fasan and G. Novelli and A. Facchiano and Burlina, {A. B.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.gene.2015.01.013",
language = "English",
volume = "559",
pages = "112--118",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier B.V.",
number = "2",

}

TY - JOUR

T1 - Clinical and molecular spectra in galactosemic patients from neonatal screening in northeastern Italy

T2 - Structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene

AU - Viggiano, E.

AU - Marabotti, A.

AU - Burlina, A. P.

AU - Cazzorla, C.

AU - D'Apice, M. R.

AU - Giordano, L.

AU - Fasan, I.

AU - Novelli, G.

AU - Facchiano, A.

AU - Burlina, A. B.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Classical galactosemia is an autosomal recessive inborn error of metabolism due to mutations of the GALT gene leading to toxic accumulation of galactose and derived metabolites. With the benefit of early diagnosis by neonatal screening and early therapy, the acute presentation of classical galactosemia can be prevented. However, despite early diagnosis and treatment, the long term outcome for these patients is still unpredictable because they may go on to develop cognitive disability, speech problems, neurological and/or movement disorders and, in females, ovarian dysfunction. The objectives of the current study were to report our experience with a group of galactosemic patients identified through the neonatal screening programs in northeastern Italy during the last 30. years.No neonatal deaths due to galactosemia complications occurred after the introduction of the neonatal screening program. However, despite the early diagnosis and dietary treatment, the patients with classical galactosemia showed one or more long-term complications.A total of 18 different variations in the GALT gene were found in the patient cohort: 12 missense, 2 frameshift, 1 nonsense, 1 deletion, 1 silent variation, and 1 intronic. Six (p.R33P, p.G83V, p.P244S, p.L267R, p.L267V, p.E271D) were new variations. The most common variation was p.Q188R (12 alleles, 31.5%), followed by p.K285N (6 alleles, 15.7%) and p.N314D (6 alleles, 15.7%). The other variations comprised 1 or 2 alleles. In the patients carrying a new mutation, the biochemical analysis of GALT activity in erythrocytes showed an activity of

AB - Classical galactosemia is an autosomal recessive inborn error of metabolism due to mutations of the GALT gene leading to toxic accumulation of galactose and derived metabolites. With the benefit of early diagnosis by neonatal screening and early therapy, the acute presentation of classical galactosemia can be prevented. However, despite early diagnosis and treatment, the long term outcome for these patients is still unpredictable because they may go on to develop cognitive disability, speech problems, neurological and/or movement disorders and, in females, ovarian dysfunction. The objectives of the current study were to report our experience with a group of galactosemic patients identified through the neonatal screening programs in northeastern Italy during the last 30. years.No neonatal deaths due to galactosemia complications occurred after the introduction of the neonatal screening program. However, despite the early diagnosis and dietary treatment, the patients with classical galactosemia showed one or more long-term complications.A total of 18 different variations in the GALT gene were found in the patient cohort: 12 missense, 2 frameshift, 1 nonsense, 1 deletion, 1 silent variation, and 1 intronic. Six (p.R33P, p.G83V, p.P244S, p.L267R, p.L267V, p.E271D) were new variations. The most common variation was p.Q188R (12 alleles, 31.5%), followed by p.K285N (6 alleles, 15.7%) and p.N314D (6 alleles, 15.7%). The other variations comprised 1 or 2 alleles. In the patients carrying a new mutation, the biochemical analysis of GALT activity in erythrocytes showed an activity of

KW - Classic galactosemia

KW - GALT variations

KW - In silico analysis

KW - Long-term outcome

UR - http://www.scopus.com/inward/record.url?scp=84922448810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922448810&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2015.01.013

DO - 10.1016/j.gene.2015.01.013

M3 - Article

VL - 559

SP - 112

EP - 118

JO - Gene

JF - Gene

SN - 0378-1119

IS - 2

ER -